Novo Nordisk shows strong fundamentals and long-term return potential despite valuation concerns and US pricing risks. Find ...

More than a dozen lawsuits filed in New York and New Jersey claim that weight-loss drugs like Wegovy and Ozempic caused ...

The conversation around Semaglutide, known widely by brand names like Ozempic and Wegovy, has undeniably captured global ...

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

The best way to address employers' concerns is to improve employee utilization of weight loss benefits, according to Saunders ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Novo Nordisk has rebounded strongly in 2025, backed by solid financials despite earlier setbacks and competitive risks. See ...

First-time patients can get discounted Wegovy through several telehealth companies ... including at its 50th anniversary party in April. Microsoft acknowledged last week that it provided AI ...

The Danish drugmaker Novo Nordisk announced it has temporarily reduced the price of the weight-loss drug Wegovy for new customers as it attempts to limit sales of compounded versions of the ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. The short-term effects of Wegovy include appetite control and weight loss. But if you’re considering taking it for the long haul ...

Wegovy has recently become very popular ... Customers can also purchase Alli from third-party retailers via the Walmart marketplace.

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers ...